Oral paricalcitol (19-nor-1,25-Dihydroxyvitamn D2) in women with metastatic breast cancer receiving taxanes or ixabepilone: A feasibility trial.
J. Lawrence
No relevant relationships to disclose
J. Lovelace
No relevant relationships to disclose
S. A. Akman
No relevant relationships to disclose
S. A. Melin
No relevant relationships to disclose
L. D. Case
No relevant relationships to disclose
G. Schwartz
No relevant relationships to disclose